In the Press

Click Above Pictures To View Articles on NexBio and DAS181 (Fludase®)

Display #
1	World Policy Journal: "The Next Pandemic", John M. Barry Summer, 2010
2	Reuters Reports on DAS181 (Fludase®) Activity for Parainfluenza June 21, 2010
3	NexBio and Weill Cornell Medical College Publish Preclinical Study Showing DAS181 (Fludase®) Anti-Influenza Drug Inhibits Parainfluenza Virus June 18, 2010
4	Clinical Trial of DAS181 (Fludase®) in Asthmatics Initiated at the National Institutes of Health May 3, 2010
5	NexBio Publishes Preclinical Study Showing DAS181 (Fludase®) Anti-Influenza Therapy Protects Against Secondary Bacterial Pneumonia Mar. 29, 2010
6	US Patent for NexBio Sialic Acid Targeting Flu Drug Tech (In-Pharma Technologist) Feb. 10, 2010
7	NexBio Granted United States Patent Covering DAS181 (Fludase®) and its Use for Prevention and Treatment of Influenza and Parainfluenza Feb. 8, 2010
8	Dr. Allen Chao, Founder & Former CEO of Watson Pharmaceuticals, Joins NexBio Board of Directors Jan. 19, 2010
9	NexBio Initiates Phase II Trial of DAS181 (Fludase®) for Treatment of Influenza, Including Pandemic Influenza A(H1N1) Jan. 7, 2010
10	National Geographic Features DAS181 (Fludase®) Dec. 22, 2009
11	NexBio Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase®) at ACAAI 2009 Nov. 9, 2009
12	NexBio Publishes Two Articles Showing DAS181 (Fludase®) Potently Inhibits Pandemic IFV A(H1N1), NAI-Resistant IFV Viruses Nov. 6, 2009
13	In Vivo Magazine Highlights US Government's Visionary Funding of Start-Ups Developing Next Gen Anti-Flu Medicines Nov. 4, 2009
14	Push is On For New Flu Drugs in Pipeline Oct. 26, 2009
15	Outbreak Shifts Feds’ Focus to New Meds Oct. 26, 2009
16	NexBio and DAS181 (Fludase®) are Featured by Chemical Engineering News Sep. 30, 2009
17	New York Times Reports on DAS181 (Fludase®) Host-Approach to Fighting Flu Sep. 21, 2009
18	NexBio Opens a New Front in the War Against Flu Sep. 15, 2009
19	NexBio Presents DAS181 (Fludase®) Potently Inhibits Novel Swine Origin A(H1N1) and NAI-Resistant Influenza Viruses at ICAAC 2009 Sep. 13, 2009
20	Reuters Reports on DAS181 (Fludase®) Activity for Tamiflu-Resistant Influenza and Novel H1N1 Sep. 13, 2009
21	NexBio Demonstrates DAS181 (Fludase®), a Broad-Spectrum Drug Candidate, Inhibits Influenza Viral Infection in Human Lung Tissue Aug. 25, 2009
22	NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase®), a First-In-Class Medicine for Influenza Apr. 15, 2009
23	New England Journal of Medicine report on Global Transmission of Oseltamivir-Resistant Influenza Mar. 5, 2009
24	NexBio Completes First-in-Man Clinical Trial With DAS181 (Fludase®) and Strengthens Clinical Leadership Jan. 19, 2009
25	NexBio to Present at 2009 Biotech Showcase Jan. 13, 2009
26	World Bank Says Flu Pandemic Could Cost $3 Trillion & 71 Million Lives Nov. 3, 2008
27	BioWorld Today, the Leading Biotech Executive Newsletter, Features NexBio and its Flagship Product, Fludase®, for Flu Pandemic & Influenza- like-Illness (ILI) Jun. 4, 2008
28	Mutant Flu Virus Is Found That Resists Popular Drug Jan. 31, 2008
29	Scientists at the CDC and NexBio Show Fludase (DAS181) Effectively Protects Animals from Lethal H5N1 Bird Flu Viral Infection Nov. 15, 2007
30	NexBio CEO, Dr. Mang Yu, is Named as a Semifinalist of the 21st San Diego "Entrepreneur of the Year" 2007 Apr. 28, 2007
31	Time Magazine: Danger from the Current Leading Flu Drug? Mar. 22, 2007
32	Science Daily Article: Highlights Receptor Binding is Critical for the Past and the Up-Coming Influenza Pandemic Feb. 5, 2007
33	Fludase as Profiled by Drug Development Technology Feb. 1, 2007
34	The New York Times: New strain of bird flu found in Egypt is resistant to antiviral drug Jan. 18, 2007
35	NPR News: FDA Orders Caution Regarding Tamiflu Nov. 14, 2006
36	Cambrex Completes cGMP Manufacture Of NexBio’s Fludase® (DAS181) Oct. 1, 2006
37	A WHO changes H5N1 Strains for Pandemic Vaccines, raising concern over virus evolution Aug. 24, 2006
38	Fish & Richardson Wins in Court for NexBio Aug. 15, 2006
39	Voice of America TV /Radio Health Forum Featuring NexBio CEO on Bird Flu (watch the 40 min. Interview and Q&A with Viewers & Listeners) May 13, 2006
40	NexBio CEO Tells NBC 7/39 TV Viewers: "The latest news on the Iraqi human case of bird flu is disturbing, but there is no reason to panic" Feb. 1, 2006
41	NexBio and Fludase Featured in the "QUEST" Section of the San Diego Union-Tribune as a Future Weapon for Pandemic Flu Jan. 25, 2006
42	MS NBC Featuring Fludase in "New Ammunition against Bird Flu in the Works" Nov. 8, 2005
43	NexBio Awarded “SCIENTIFIC AMERICAN 50” For Its Quest For the Ultimate Influenza Medicine Nov. 8, 2005
44	Channel 10/ABC NEWS Broadcasts a Live Interview with NexBio's CSO /CMO in Response to President Bush's $7.1 B Flu Plan Nov. 1, 2005
45	Fortune Magazine Interviews NexBio CEO & CSO /CMO for Their Expert Opinions Fortune Magazine Interviews NexBio CEO & CSO /CMO for Their Expert Opinions Oct. 31, 2005
46	NexBio's First News Release: NexBio Awarded a $6 Million NIH SBIR Grant for the Clinical Development of a Novel Influenza Medicine (PDF) Aug. 8, 2005
47	Nature News Article Calling for "Quantum Leap" Development for Flu Medicine and Featuring NexBio & Fludase May 26, 2005
48	Genetic Engineering News Featuring a Full Corporate & Product Profile on NexBio & Fludase (PDF) Apr. 10, 2005
49	ABC/Channel 10 NEWS Features NexBio and Fludase (watch the 2.2 min. TV news here by clicking on this link) Jan. 20, 2005
50	NexBio's Chief Scientific & Medical Officer Featured in the "People to Watch" in the Life Sciences Industry by San Diego Union Tribune Jan. 28, 2005
«StartPrev12Next End»
Page 1 of 2